Therapeutic advances in acute myeloid leukemia.

@article{Burnett2011TherapeuticAI,
  title={Therapeutic advances in acute myeloid leukemia.},
  author={Alan K. Burnett and Meir Wetzler and Bob L{\"o}wenberg},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2011},
  volume={29 5},
  pages={487-94}
}
The choice of treatment approach and outcome in acute myeloid leukemia (AML) depends on the age of the patient. In younger patients, arbitrarily defined as being younger than 60 years, 70% to 80% enter complete disease remission with several anthracycline-based chemotherapy combinations. Consolidation with high-dose cytarabine or stem-cell transplantation in high-risk patients will restrict overall relapse to approximately 50%. A number of demographic features can predict the outcome of… CONTINUE READING
Highly Influential
This paper has highly influenced 11 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 268 extracted citations

Similar Papers

Loading similar papers…